Lymphoma, Large B-Cell, Diffuse

Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

3 drugs in development·1 company·5 clinical trials

Drug Pipeline by Phase

Compare drugs

Polatuzumab vedotin vs Rescue MedicationPolatuzumab vedotin vs Zilovertamab vedotin

Frequently asked questions

How many drugs are in development for Lymphoma, Large B-Cell, Diffuse?

BioSniper tracks 3 drugs in development for Lymphoma, Large B-Cell, Diffuse across 1 company.

How many clinical trials target Lymphoma, Large B-Cell, Diffuse?

There are 5 clinical trials targeting Lymphoma, Large B-Cell, Diffuse tracked by BioSniper.

What is the prevalence of Lymphoma, Large B-Cell, Diffuse?

The estimated prevalence of Lymphoma, Large B-Cell, Diffuse is approximately 56.0 per 100,000 population.

Deep-dive into Lymphoma, Large B-Cell, Diffuse

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Lymphoma, Large B-Cell, Diffuse — Drugs in Development & Clinical Trials | BioSniper